Discontinuation report ULORIC
Report ID | 144266 |
Drug Identification Number | 02357380 |
Brand name | ULORIC |
Common or Proper name | ULORIC 80 mg Tablets |
Company Name | TAKEDA CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FEBUXOSTAT |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Bottle of 30's |
ATC code | M04AA |
ATC description | ANTIGOUT PREPARATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-12-31 |
Actual discontinuation date | 2021-12-31 |
Remaining supply date | 2021-12-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-01-04 | French | Compare |
v3 | 2022-01-04 | English | Compare |
v2 | 2021-08-17 | French | Compare |
v1 | 2021-08-17 | English | Compare |
Showing 1 to 4 of 4